Northern Ireland written question – answered at on 18 November 2004.
Iris Robinson
DUP, Strangford
To ask the Secretary of State for Northern Ireland how much was spent on (a) haemophilia and (b) haematology drugs in the Province in each of the last five years; and what the expected spending is over the next 12 months.
Angela Smith
Parliamentary Under-Secretary, Northern Ireland Office, Parliamentary Under-Secretary (Northern Ireland Office)
We estimate that the total spend on treating persons with haemophilia in a hospital in-patient or day case environment in Northern Ireland was approximately £197,000 in 2002–03 and £79,000 in 2001–02. The bulk of services to haemophiliacs are, however, provided in an out-patient primary care or community environment.
Blood products used by haemophiliacs are provided by the NI Blood Transfusion Service (NIBTS) and cost as follows:
| £ million | |
|---|---|
| 2004–05 (predicted) | 8.25 |
| 2003–04 | 7.7 |
| 2002–03 | 5.9 |
| 2001–02 | 5.2 |
| 2000–01 | 4.7 |
| 1999–2000 | 4.0 |
The total spend on chemotherapy drugs in the haematology specialty was approximately in £1.341million 2002–03 and £1.64 million in 2003–04. 2004–05 has experienced expansion in demand to approximately £3.7million.
Further information is not available.
Yes1 person thinks so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
